| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8508064 | Actualités Pharmaceutiques | 2018 | 5 Pages |
Abstract
Cardiovascular diseases are the second cause of death in France. Dyslipidaemia represents, along with diabetes, arterial hypertension and smoking, a major risk factor of atherosclerosis, itself a factor in the occurrence of these diseases. The French national health authority recently published recommendations regarding treatment strategies.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
François (Pharmacologue),